About this trial
Androgenetic alopecia (AGA)is the most common form of alopecia. It predominantly affects males, but there has been a significant surge in female preponderance too, over the last decade Minoxidil belong to the anti-hypertensive class but it also affects the potassium channels present in vascular smooth muscles and hair follicles. This potassium channel activity may stimulate the microcirculation around the hair follicles and induces arteriolar vasodilation, thereby encouraging conditions conducive to hair growth Topical administration of finasteride offers the potential to reduce systemic effects related to its mechanism of action by preferentially inhibiting 5-a reductase in the scalp, as has been suggested in recent years so in this study we are going to compare efficacy of topical minoxidil versus topical finasteride in treatment of androgenetic alopecia
Eligibility criteria
Qualifiers
Age: 20-50 years
Gender: Male
ANDROGENETIC ALOPECIA with AGA stage 2-6 Norwood-Hamilton -classification
Patients not taking any treatment in last 1 month
Disqualifiers
Abrasion or abnormalities to the scalp
Hair transplant
Hypersensitivity
Recent history of local infections of the head
Trial design
Treatments tested in this trial
- topical finasteride
- Topical minoxidil